Global and China Parkinson's Disease Drug Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Parkinson's Disease Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Orion

    • Akorn

    • Apokyn

    • Valeant Pharmaceuticals

    • Desitin Arzneimittel

    • Teva Pharmaceutical

    • GSK

    • Endo Pharmaceuticals

    • Abbvie

    • Novartis

    • Boehringer Ingelheim

    • US WorldMeds

    • Kyowa Hakko Kirin Pharma

    • Valeant

    • Astellas Pharma

    • Stada Arzneimittel

    • US WorldMeds Pharmaceuticals

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Sinemet-CR

    • Trastal

    • Madopar

    • COMT Inhibitor

    • Others

    Application:

    • Under 40 Years Old

    • 40-65 Years Old

    • Above 65 Years Old

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Parkinson's Disease Drug Industry Overview

      • 1.1.1 Parkinson's Disease Drug Market Scope and Market Segments

      • 1.1.2 Parkinson's Disease Drug Industry Characteristics

      • 1.1.3 Global and China Parkinson's Disease Drug Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Parkinson's Disease Drug Production Value and Growth Rate (2017-2028)

    • 1.2 Global Parkinson's Disease Drug Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Sinemet-CR

      • 1.2.2 Trastal

      • 1.2.3 Madopar

      • 1.2.4 COMT Inhibitor

      • 1.2.5 Others

    • 1.3 Global Parkinson's Disease Drug Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Under 40 Years Old

      • 1.3.2 40-65 Years Old

      • 1.3.3 Above 65 Years Old

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Parkinson's Disease Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Parkinson's Disease Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Parkinson's Disease Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Parkinson's Disease Drug Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Parkinson's Disease Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Parkinson's Disease Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Parkinson's Disease Drug Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Parkinson's Disease Drug Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Parkinson's Disease Drug Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Parkinson's Disease Drug Industry Porter's Five Forces Model Analysis

      • 2.2.3 Parkinson's Disease Drug Industry PEST Analysis

    • 2.3 Parkinson's Disease Drug Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Parkinson's Disease Drug Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Parkinson's Disease Drug Industry

    Chapter 3 Global and China Parkinson's Disease Drug Market, by Manufacturer

    • 3.1 Global and China Parkinson's Disease Drug Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Parkinson's Disease Drug Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Parkinson's Disease Drug Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Parkinson's Disease Drug Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Parkinson's Disease Drug Market Top 3 Players

    Chapter 4 Global and China Parkinson's Disease Drug Market, by Type (2017-2028)

    • 4.1 Parkinson's Disease Drug Market Trend, by Type

    • 4.2 Global Parkinson's Disease Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Parkinson's Disease Drug Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Parkinson's Disease Drug Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Parkinson's Disease Drug Price Trend, by Type (2017-2028)

    • 4.3 China Parkinson's Disease Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Parkinson's Disease Drug Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Parkinson's Disease Drug Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Parkinson's Disease Drug Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Parkinson's Disease Drug Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Parkinson's Disease Drug Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Parkinson's Disease Drug Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Parkinson's Disease Drug Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Parkinson's Disease Drug Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Parkinson's Disease Drug Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Parkinson's Disease Drug Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Parkinson's Disease Drug Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Parkinson's Disease Drug Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Parkinson's Disease Drug Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Parkinson's Disease Drug Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Parkinson's Disease Drug Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Parkinson's Disease Drug Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Parkinson's Disease Drug Market Analysis

    • 7.1 North America Parkinson's Disease Drug Market, by Type

    • 7.2 North America Parkinson's Disease Drug Market, by Application

    • 7.3 North America Parkinson's Disease Drug Market Analysis and Forecast, by Country

      • 7.3.1 United States Parkinson's Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Parkinson's Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Parkinson's Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Parkinson's Disease Drug Market Analysis

    • 8.1 Europe Parkinson's Disease Drug Market, by Type

    • 8.2 Europe Parkinson's Disease Drug Market, by Application

    • 8.3 Europe Parkinson's Disease Drug Market Analysis and Forecast, by Country

      • 8.3.1 Germany Parkinson's Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Parkinson's Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Parkinson's Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Parkinson's Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Parkinson's Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Parkinson's Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Parkinson's Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Parkinson's Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Parkinson's Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Parkinson's Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Parkinson's Disease Drug Market Analysis

    • 9.1 APAC Parkinson's Disease Drug Market, by Type

    • 9.2 APAC Parkinson's Disease Drug Market, by Application

    • 9.3 APAC Parkinson's Disease Drug Market Analysis and Forecast, by Country

      • 9.3.1 China Parkinson's Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Parkinson's Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Parkinson's Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Parkinson's Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Parkinson's Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Parkinson's Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Parkinson's Disease Drug Market Analysis

    • 10.1 Latin America, Middle East and Africa Parkinson's Disease Drug Market, by Type

    • 10.2 Latin America, Middle East and Africa Parkinson's Disease Drug Market, by Application

    • 10.3 Latin America, Middle East and Africa Parkinson's Disease Drug Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Parkinson's Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Parkinson's Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Parkinson's Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Parkinson's Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Parkinson's Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Parkinson's Disease Drug Company Profiles

      • 11.1 Orion

        • 11.1.1 Orion Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Orion Parkinson's Disease Drug Product Profiles, Application and Specification

        • 11.1.3 Orion Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Akorn

        • 11.2.1 Akorn Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Akorn Parkinson's Disease Drug Product Profiles, Application and Specification

        • 11.2.3 Akorn Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Apokyn

        • 11.3.1 Apokyn Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Apokyn Parkinson's Disease Drug Product Profiles, Application and Specification

        • 11.3.3 Apokyn Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Valeant Pharmaceuticals

        • 11.4.1 Valeant Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Valeant Pharmaceuticals Parkinson's Disease Drug Product Profiles, Application and Specification

        • 11.4.3 Valeant Pharmaceuticals Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Desitin Arzneimittel

        • 11.5.1 Desitin Arzneimittel Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Desitin Arzneimittel Parkinson's Disease Drug Product Profiles, Application and Specification

        • 11.5.3 Desitin Arzneimittel Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Teva Pharmaceutical

        • 11.6.1 Teva Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Teva Pharmaceutical Parkinson's Disease Drug Product Profiles, Application and Specification

        • 11.6.3 Teva Pharmaceutical Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 GSK

        • 11.7.1 GSK Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 GSK Parkinson's Disease Drug Product Profiles, Application and Specification

        • 11.7.3 GSK Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Endo Pharmaceuticals

        • 11.8.1 Endo Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Endo Pharmaceuticals Parkinson's Disease Drug Product Profiles, Application and Specification

        • 11.8.3 Endo Pharmaceuticals Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Abbvie

        • 11.9.1 Abbvie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Abbvie Parkinson's Disease Drug Product Profiles, Application and Specification

        • 11.9.3 Abbvie Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Novartis

        • 11.10.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Novartis Parkinson's Disease Drug Product Profiles, Application and Specification

        • 11.10.3 Novartis Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Boehringer Ingelheim

        • 11.11.1 Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Boehringer Ingelheim Parkinson's Disease Drug Product Profiles, Application and Specification

        • 11.11.3 Boehringer Ingelheim Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 US WorldMeds

        • 11.12.1 US WorldMeds Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 US WorldMeds Parkinson's Disease Drug Product Profiles, Application and Specification

        • 11.12.3 US WorldMeds Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Kyowa Hakko Kirin Pharma

        • 11.13.1 Kyowa Hakko Kirin Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Product Profiles, Application and Specification

        • 11.13.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Valeant

        • 11.14.1 Valeant Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Valeant Parkinson's Disease Drug Product Profiles, Application and Specification

        • 11.14.3 Valeant Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Astellas Pharma

        • 11.15.1 Astellas Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Astellas Pharma Parkinson's Disease Drug Product Profiles, Application and Specification

        • 11.15.3 Astellas Pharma Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Stada Arzneimittel

        • 11.16.1 Stada Arzneimittel Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Stada Arzneimittel Parkinson's Disease Drug Product Profiles, Application and Specification

        • 11.16.3 Stada Arzneimittel Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.17 US WorldMeds Pharmaceuticals

        • 11.17.1 US WorldMeds Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.17.2 US WorldMeds Pharmaceuticals Parkinson's Disease Drug Product Profiles, Application and Specification

        • 11.17.3 US WorldMeds Pharmaceuticals Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Parkinson's Disease Drug Industry Investment Prospect and Risk Assessment

    • 12.1 Parkinson's Disease Drug Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Parkinson's Disease Drug Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Parkinson's Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure China Parkinson's Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Global Parkinson's Disease Drug Production Value and Growth Rate (2017-2028)

    • Figure China Parkinson's Disease Drug Production Value and Growth Rate (2017-2028)

    • Figure Global Parkinson's Disease Drug Market Size and Growth Rate of Sinemet-CR (2017-2028)

    • Figure Global Parkinson's Disease Drug Market Size and Growth Rate of Trastal (2017-2028)

    • Figure Global Parkinson's Disease Drug Market Size and Growth Rate of Madopar (2017-2028)

    • Figure Global Parkinson's Disease Drug Market Size and Growth Rate of COMT Inhibitor (2017-2028)

    • Figure Global Parkinson's Disease Drug Market Size and Growth Rate of Others (2017-2028)

    • Figure Global Parkinson's Disease Drug Market Size and Growth Rate of Under 40 Years Old (2017-2028)

    • Figure Global Parkinson's Disease Drug Market Size and Growth Rate of 40-65 Years Old (2017-2028)

    • Figure Global Parkinson's Disease Drug Market Size and Growth Rate of Above 65 Years Old (2017-2028)

    • Figure North America Parkinson's Disease Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Parkinson's Disease Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Parkinson's Disease Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Parkinson's Disease Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Parkinson's Disease Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Parkinson's Disease Drug Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Parkinson's Disease Drug Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Parkinson's Disease Drug Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Parkinson's Disease Drug Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Parkinson's Disease Drug Market Share, by Manufacturer in 2021

    • Figure Global and China Parkinson's Disease Drug Market Share, by Manufacturer in 2022

    • Table Global Parkinson's Disease Drug Sales Volume, by Type (2017-2028)

    • Table Global Parkinson's Disease Drug Sales Volume Share, by Type (2017-2028)

    • Figure Global Parkinson's Disease Drug Sales Volume Share, by Type (2017-2028)

    • Table Global Parkinson's Disease Drug Sales Value, by Type (2017-2028)

    • Table Global Parkinson's Disease Drug Sales Value Share, by Type (2017-2028)

    • Figure Global Parkinson's Disease Drug Price Trend, by Type (2017-2028)

    • Table China Parkinson's Disease Drug Sales Volume, by Type (2017-2028)

    • Table China Parkinson's Disease Drug Sales Volume Share, by Type (2017-2028)

    • Figure China Parkinson's Disease Drug Sales Volume Share, by Type (2017-2028)

    • Table China Parkinson's Disease Drug Sales Value, by Type (2017-2028)

    • Table China Parkinson's Disease Drug Sales Value Share, by Type (2017-2028)

    • Figure China Parkinson's Disease Drug Price Trend, by Type (2017-2028)

    • Table Global Parkinson's Disease Drug Sales Volume, by Application (2017-2028)

    • Table Global Parkinson's Disease Drug Sales Volume Share, by Application (2017-2028)

    • Figure Global Parkinson's Disease Drug Sales Volume Share, by Application (2017-2028)

    • Table Global Parkinson's Disease Drug Sales Value, by Application (2017-2028)

    • Table Global Parkinson's Disease Drug Sales Value Share, by Application (2017-2028)

    • Figure Global Parkinson's Disease Drug Sales Value Share, by Application (2017-2028)

    • Table China Parkinson's Disease Drug Sales Volume, by Application (2017-2028)

    • Table China Parkinson's Disease Drug Sales Volume Share, by Application (2017-2028)

    • Figure China Parkinson's Disease Drug Sales Volume Share, by Application (2017-2028)

    • Table China Parkinson's Disease Drug Sales Value, by Application (2017-2028)

    • Table China Parkinson's Disease Drug Sales Value Share, by Application (2017-2028)

    • Figure China Parkinson's Disease Drug Sales Value Share, by Application (2017-2028)

    • Figure China Parkinson's Disease Drug Production, Import, Consumption and Export (2017-2022)

    • Figure North America Parkinson's Disease Drug Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Parkinson's Disease Drug Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Parkinson's Disease Drug Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Parkinson's Disease Drug Production, Import, Consumption and Export (2017-2022)

    • Table North America Parkinson's Disease Drug Sales Volume, by Type (2017-2028)

    • Table North America Parkinson's Disease Drug Sales Volume Share, by Type (2017-2028)

    • Figure North America Parkinson's Disease Drug Sales Volume Share, by Type (2017-2028)

    • Table North America Parkinson's Disease Drug Sales Volume, by Application (2017-2028)

    • Table North America Parkinson's Disease Drug Sales Volume Share, by Application (2017-2028)

    • Figure North America Parkinson's Disease Drug Sales Volume Share, by Application (2017-2028)

    • Figure United States Parkinson's Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure United States Parkinson's Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure Canada Parkinson's Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Parkinson's Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Parkinson's Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Parkinson's Disease Drug Sales Value and Growth Rate (2017-2028)

    • Table Europe Parkinson's Disease Drug Sales Volume, by Type (2017-2028)

    • Table Europe Parkinson's Disease Drug Sales Volume Share, by Type (2017-2028)

    • Figure Europe Parkinson's Disease Drug Sales Volume Share, by Type (2017-2028)

    • Table Europe Parkinson's Disease Drug Sales Volume, by Application (2017-2028)

    • Table Europe Parkinson's Disease Drug Sales Volume Share, by Application (2017-2028)

    • Figure Europe Parkinson's Disease Drug Sales Volume Share, by Application (2017-2028)

    • Figure Germany Parkinson's Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Parkinson's Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure UK Parkinson's Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure UK Parkinson's Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure France Parkinson's Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure France Parkinson's Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure Italy Parkinson's Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Parkinson's Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Parkinson's Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Parkinson's Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure Spain Parkinson's Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Parkinson's Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Parkinson's Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Parkinson's Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure Poland Parkinson's Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Parkinson's Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure Russia Parkinson's Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Parkinson's Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Parkinson's Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Parkinson's Disease Drug Sales Value and Growth Rate (2017-2028)

    • Table APAC Parkinson's Disease Drug Sales Volume, by Type (2017-2028)

    • Table APAC Parkinson's Disease Drug Sales Volume Share, by Type (2017-2028)

    • Figure APAC Parkinson's Disease Drug Sales Volume Share, by Type (2017-2028)

    • Table APAC Parkinson's Disease Drug Sales Volume, by Application (2017-2028)

    • Table APAC Parkinson's Disease Drug Sales Volume Share, by Application (2017-2028)

    • Figure APAC Parkinson's Disease Drug Sales Volume Share, by Application (2017-2028)

    • Figure China Parkinson's Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure China Parkinson's Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure Japan Parkinson's Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Parkinson's Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Parkinson's Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Parkinson's Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure India Parkinson's Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure India Parkinson's Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Parkinson's Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Parkinson's Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Parkinson's Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Parkinson's Disease Drug Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Parkinson's Disease Drug Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Parkinson's Disease Drug Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Parkinson's Disease Drug Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Parkinson's Disease Drug Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Parkinson's Disease Drug Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Parkinson's Disease Drug Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Parkinson's Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Parkinson's Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Parkinson's Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Parkinson's Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Parkinson's Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Parkinson's Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Parkinson's Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Parkinson's Disease Drug Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Parkinson's Disease Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Parkinson's Disease Drug Sales Value and Growth Rate (2017-2028)

    • Table Orion Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Orion Product Profiles, Application and Specification

    • Table Orion Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Akorn Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Akorn Product Profiles, Application and Specification

    • Table Akorn Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Apokyn Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Apokyn Product Profiles, Application and Specification

    • Table Apokyn Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Valeant Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Valeant Pharmaceuticals Product Profiles, Application and Specification

    • Table Valeant Pharmaceuticals Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Desitin Arzneimittel Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Desitin Arzneimittel Product Profiles, Application and Specification

    • Table Desitin Arzneimittel Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Teva Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Teva Pharmaceutical Product Profiles, Application and Specification

    • Table Teva Pharmaceutical Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GSK Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GSK Product Profiles, Application and Specification

    • Table GSK Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Endo Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Endo Pharmaceuticals Product Profiles, Application and Specification

    • Table Endo Pharmaceuticals Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Abbvie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abbvie Product Profiles, Application and Specification

    • Table Abbvie Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis Product Profiles, Application and Specification

    • Table Novartis Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Boehringer Ingelheim Product Profiles, Application and Specification

    • Table Boehringer Ingelheim Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table US WorldMeds Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table US WorldMeds Product Profiles, Application and Specification

    • Table US WorldMeds Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Kyowa Hakko Kirin Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Kyowa Hakko Kirin Pharma Product Profiles, Application and Specification

    • Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Valeant Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Valeant Product Profiles, Application and Specification

    • Table Valeant Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Astellas Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astellas Pharma Product Profiles, Application and Specification

    • Table Astellas Pharma Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Stada Arzneimittel Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Stada Arzneimittel Product Profiles, Application and Specification

    • Table Stada Arzneimittel Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table US WorldMeds Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table US WorldMeds Pharmaceuticals Product Profiles, Application and Specification

    • Table US WorldMeds Pharmaceuticals Parkinson's Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.